第一金融网主办
 | 网站首页 | 金融焦点 | 银行 | 股票 | 基金 | 保险 | 期货 | 股评 | 港股 | 美股 | 外汇 | 债券 | 黄金 | 理财 | 信托 | 房产 | 汽车 | 行情 | 
»您现在的位置: 第一金融网 >> 金融焦点 >> 文传商讯 >> 正文

New survey reveals 9 out of 10 patients with IPF were happy with how their doctor told them about their IPF diagnosis

2016/9/22 7:58:10  文章来源:文传商讯  作者:文传商讯
文章简介: However,needforadditionalinformationtohelppatientsatIPFdiagnosisidentified Surveyalsorevealedthatphysicians’understandingofth
  • However, need for additional information to help patients at IPF diagnosis identified
  • Survey also revealed that physicians’ understanding of their patients’ priorities were aligned with patients' actual priorities at diagnosis

INGELHEIM, Germany -- (BUSINESS WIRE) --

A diagnosis of IPF is news that few patients want to hear from their physician, but the reality is that approximately 3 million people worldwide are living with idiopathic pulmonary fibrosis (IPF). It’s a rare and devastating disease with a median life expectancy after diagnosis of approximately 2-3 years.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160920006002/en/

As with the diagnosis of any life-threatening disease, it can be a distressing and emotional experience for patients and their families. It is a time when it can be difficult to take the news in as well as remember/understand the information shared by a doctor.

In positive news, today results of a new global survey supported by Boehringer Ingelheim of over 120 patients with IPF show that 9 out of 10 patients were happy with the way their doctor informed them of their diagnosis.

However, a group of patients in the survey revealed there was additional information that would have been helpful to have received at that time. These include information about support, treatment and the realities of living with IPF:

  • 60% of patients would like to have known what other support was available to help with their IPF
  • 60% wanted to know if IPF requires long-term treatment and how effective those treatments are
  • 50% of patients wanted an insight into the realities of living with IPF over the long term
  • 50% wanted an understanding of how their IPF would progress after treatment initiation, including if they will need to take oxygen

“A diagnosis of IPF is devastating for the patient, their partner, for everyone. It is very reassuring to see from this survey that these patients felt positive about how their physician managed their diagnosis discussion,” said Klaus Geissler, European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF). “But we know that when patients are stressed and anxious that they can forget or not understand key parts of the conversation they have with their physician: it’s helpful for us to see that patients are keen to have more information about the support that will be available to them and details of treatment moving forward. I would recommend patients involve their families in the first interview with their physician in order to better understand and remember the discussion around diagnosis.”

The new global survey of 121 patients with IPF follows a 2015 global survey of over 400 pulmonologists. Both surveys were designed to provide insights into IPF and the realities of living with the condition.

The new results revealed that the priorities for patients after being diagnosed with IPF closely matched what physicians believed their patients’ priorities were at that time.

  • The top three priorities for patients were: seeing an IPF specialist (26%), getting information about the disease (21%) and initiation of an effective treatment (18%).
  • The top three priorities physicians believed their patients had were: getting information about the disease (35%), initiating an effective treatment (23%) and seeing an IPF specialist (21%).

In addition, when patients were asked what was most important to them in knowing how IPF will affect them, ‘Knowing what treatment options are available to me’ was the top choice for patients (77%). In the 2015 pulmonologist survey, this was also the top choice for what physicians believed was most important to patients (77%).

“As a physician it’s encouraging to see the majority of patients happy with how they were informed about their IPF diagnosis,” said Dr. Marlies Wijsenbeek, pulmonologist, Erasmus MC, The Netherlands. “But good communication doesn’t stop there – we need to understand what patients wish to know and take into consideration their level of understanding. Seeing that physicians’ understanding of patients’ priorities are truly aligned with what patients report to be their priorities is a great first step to achieving this.”

At Boehringer Ingelheim we recognise the importance of sharing information so that patients and their families are informed about this serious disease. To coincide with the launch of the survey results, we are pleased to also share ‘Life with IPF – an eBook’. Available on www.LifewithIPF.com the e-book describes the IPF patient journey, from diagnosis and what to expect, through to management options and helpful resources and tips.

Also available through Google Play: https://bit.ly/2czw8Zi and iTunes: apple.co/2cLuw0a

Stay tuned for the next insights from the survey in early 2017 to coincide with Rare Disease Day 2017.

~ ENDS ~

Please click on the link below for ‘Notes to Editors’ and ‘References’:

http://www.boehringer-ingelheim.com/press-release/new-survey-about-ipf-diagnosis

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160920006002/en/

 

CONTACT:

Boehringer Ingelheim
Corporate Communications
Media + PR
Dr. Kristin Jakobs
Phone: +49 6132 – 77 144553
Fax: +49 6132 – 77 6601
Email: press@boehringeringelheim.com

IPF patient survey infographic (Photo: Business Wire)

分享到:
第一金融网免责声明:
1、本网站中的文章(包括转贴文章)的版权仅归原作者所有,若作者有版权声明的或文章从其它网站转载而附带有原所有站的版权声明者,其版权归属以附带声明为准。
2、文章来源为均为其它媒体的转载文章,我们会尽可能注明出处,但不排除来源不明的情况。转载是处于提供更多信息以参考使用或学习、交流、科研之目的,不用于 商业用途。转载无意侵犯版权,如转载文章涉及您的权益等问题,请作者速来电话和函告知,我们将尽快处理。来信:fengyueyoubian#sina.com (请将#改为@)。
3、本网站所载文章、数据、网友投稿等内容纯属作者个人观点,仅供投资者参考,并不构成投资建议,与第一金融网站无关。投资者据此操作,风险自担。如对本文内容有疑义,请及时与我们联系。
发表评论

【发表评论】(网友评论内容只代表网友观点,与本站立场无关!)
 姓 名:
 评 分: 1分 2分 3分 4分 5分
 评论内容:
验证码:   *
  • 请遵守《互联网电子公告服务管理规定》及中华人民共和国其他各项有关法律法规。
  • 严禁发表危害国家安全、损害国家利益、破坏民族团结、破坏国家宗教政策、破坏社会稳定、侮辱、诽谤、教唆、淫秽等内容的评论 。
  • 用户需对自己在使用本站服务过程中的行为承担法律责任(直接或间接导致的)。
  • 本站管理员有权保留或删除评论内容。
  • 评论内容只代表网友个人观点,与本网站立场无关。
  • 全站精选
    [新闻]  国行note7二炸机主:三星根本没回收检测其手机
     长江危急!水库泄洪湖北万吨养殖鲟鱼逃逸 或造成
    [银行]  银行业票据大案频发亟待整治 近十年涉案总额达2
     收费降低 银行刷卡手续费新规今起施行
    [股票]  明日股市三大猜想及应对策略:券商股能否引领大
     周四机构一致最看好的3金股
    [基金]  保险资管投资经理涉老鼠仓案 交易1.2亿获利几十
     上海警方“猎狐”破获“老鼠仓”案 涉案金额超亿
    [保险]  保监会对农险违规开16张罚单 人保财险罚单最多
     社保和商保真正的区别——案例演示
    [期货]  期货疯狂 黑色系再现涨停潮
     国际油价难超40美元地板价 国内成品油价短期锁死
    [股评]  机构预测明日大盘走势(9/22)
     券商评级:券商盘中昙花一现 12股望爆发(9/22)
    [港股]  中秋金融市场休市安排:A股连休4天 港股通关闭6
     深港通4个月后“发车” 散户无法买创业板股
    [美股]  三星回应国行Note 7发生电池爆炸:还在调查中
     三星“炸飞”数百亿美元市值 韩国经济受惊吓
    [外汇]  人民币兑美元中间价上调365点 为2005年来最大调
     人民币兑美元中间价贬值196点 降幅逾两月最大
    [债券]  债市反腐风暴延续 消息称多行债券投资经理被抓
     央行今日进行1100亿元7天期逆回购 中标利率2.25
    [黄金]  互金协会禁令:禁止以“创始会员”名义宣传
     黄金热下的黑平台骗局:宣称百分百盈利 诱使客户
    [理财]  隐形富豪胡歌身价上亿 盘点娱乐圈深藏不漏的富豪
     当年马云创建阿里巴巴的十八罗汉如今在干什么【
    [信托]  上周集合信托成立35款 房地产领域占比超30%
     信托成立市场再遭“腰斩”
    [房产]  瑞银:中国房地产大涨和杠杆高企已让决策者担心
     许小年:房地产不可能支撑中国经济这么大的体量
    [汽车]  东风悦达起亚新KX3正式上市 11.68万元起
     6.98万元起 潍柴英致G5火热开启预售
  • 此栏目下没有推荐文章
  • | 设为首页 | 加入收藏 | 关于我们 | 友情链接 | 版权申明 | 文章列表 | 网站地图 | 征稿启事 | 广告服务 | 意见反馈 |

    Copyright©2006-2016 afinance.cn All Rights Reserved 版权所有·第一金融网